Gallo SA - Search Results

1

Gallo SA, Finnegan CM, Viard M, Raviv Y, Dimitrov A, Rawat SS, Puri A, Durell S, Blumenthal R. Gallo SA, et al. Biochim Biophys Acta. 2003 Jul 11;1614(1):36-50. doi: 10.1016/s0005-2736(03)00161-5. Biochim Biophys Acta. 2003. PMID: 12873764 Free article. Review.

2

Fluorescent lipid probes in the study of viral membrane fusion.

Blumenthal R, Gallo SA, Viard M, Raviv Y, Puri A. Blumenthal R, et al. Among authors: gallo sa. Chem Phys Lipids. 2002 Jun;116(1-2):39-55. doi: 10.1016/s0009-3084(02)00019-1. Chem Phys Lipids. 2002. PMID: 12093534 Review.

3

Modulation of entry of enveloped viruses by cholesterol and sphingolipids (Review).

Rawat SS, Viard M, Gallo SA, Rein A, Blumenthal R, Puri A. Rawat SS, et al. Among authors: gallo sa. Mol Membr Biol. 2003 Jul-Sep;20(3):243-54. doi: 10.1080/0968768031000104944. Mol Membr Biol. 2003. PMID: 12893532 Free article. Review.

4

Functional expression of CD4, CXCR4, and CCR5 in glycosphingolipid-deficient mouse melanoma GM95 cells and susceptibility to HIV-1 envelope glycoprotein-triggered membrane fusion.

Rawat SS, Eaton J, Gallo SA, Martin TD, Ablan S, Ratnayake S, Viard M, KewalRamani VN, Wang JM, Blumenthal R, Puri A. Rawat SS, et al. Among authors: gallo sa. Virology. 2004 Jan 5;318(1):55-65. doi: 10.1016/j.virol.2003.08.042. Virology. 2004. PMID: 14972535 Free article.

5

The stability of the intact envelope glycoproteins is a major determinant of sensitivity of HIV/SIV to peptidic fusion inhibitors.

Gallo SA, Sackett K, Rawat SS, Shai Y, Blumenthal R. Gallo SA, et al. J Mol Biol. 2004 Jun 25;340(1):9-14. doi: 10.1016/j.jmb.2004.04.027. J Mol Biol. 2004. PMID: 15184018

6

Temperature-dependent intermediates in HIV-1 envelope glycoprotein-mediated fusion revealed by inhibitors that target N- and C-terminal helical regions of HIV-1 gp41.

Gallo SA, Clore GM, Louis JM, Bewley CA, Blumenthal R. Gallo SA, et al. Biochemistry. 2004 Jun 29;43(25):8230-3. doi: 10.1021/bi049957v. Biochemistry. 2004. PMID: 15209519

7

Elevated expression of GM3 in receptor-bearing targets confers resistance to human immunodeficiency virus type 1 fusion.

Rawat SS, Gallo SA, Eaton J, Martin TD, Ablan S, KewalRamani VN, Wang JM, Blumenthal R, Puri A. Rawat SS, et al. Among authors: gallo sa. J Virol. 2004 Jul;78(14):7360-8. doi: 10.1128/JVI.78.14.7360-7368.2004. J Virol. 2004. PMID: 15220409 Free PMC article.

8

Theta-defensins prevent HIV-1 Env-mediated fusion by binding gp41 and blocking 6-helix bundle formation.

Gallo SA, Wang W, Rawat SS, Jung G, Waring AJ, Cole AM, Lu H, Yan X, Daly NL, Craik DJ, Jiang S, Lehrer RI, Blumenthal R. Gallo SA, et al. J Biol Chem. 2006 Jul 7;281(27):18787-92. doi: 10.1074/jbc.M602422200. Epub 2006 Apr 28. J Biol Chem. 2006. PMID: 16648135 Free article.

9

Sphingolipids, cholesterol, and HIV-1: a paradigm in viral fusion.

Rawat SS, Viard M, Gallo SA, Blumenthal R, Puri A. Rawat SS, et al. Among authors: gallo sa. Glycoconj J. 2006 May;23(3-4):189-97. doi: 10.1007/s10719-006-7924-4. Glycoconj J. 2006. PMID: 16691502

10

Kinetic studies of HIV-1 and HIV-2 envelope glycoprotein-mediated fusion.

Gallo SA, Reeves JD, Garg H, Foley B, Doms RW, Blumenthal R. Gallo SA, et al. Retrovirology. 2006 Dec 4;3:90. doi: 10.1186/1742-4690-3-90. Retrovirology. 2006. PMID: 17144914 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters